# Cangrelor to Clopidogrel or Prasugrel Transition Study

> **NCT01979445** · PHASE2 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 15 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)

## Interventions

- **DRUG:** Cangrelor
- **DRUG:** Clopidogrel
- **DRUG:** Prasugrel

## Key facts

- **NCT ID:** NCT01979445
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-02
- **Primary completion:** 2014-01-20
- **Final completion:** 2014-01-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01979445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01979445, "Cangrelor to Clopidogrel or Prasugrel Transition Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01979445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*